JusticeItaly Official institution

Italy authorizes Dimetilfumarato Cipla, a dimethyl fumarate medicine

Italy's medicines agency AIFA has published a notice authorizing the sale of a human medicine called 'Dimetilfumarato Cipla', which contains dimethyl fumarate. The notice was published on 7 November 2026 and carries reference number 26A05786. The document provided does not name the license holder, strengths, or pack sizes.

This summary was generated by AI; the official source prevails.

Who is affected?

Patients in Italy who are prescribed dimethyl fumarate-based treatment, and doctors and pharmacies who may supply it.